BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32846853)

  • 1. Clinical characteristics and prognostic analysis of Chinese dermatomyositis patients with malignancies.
    Shao C; Li S; Sun Y; Zhang Y; Xu K; Zhang X; Huang H
    Medicine (Baltimore); 2020 Aug; 99(34):e21899. PubMed ID: 32846853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.
    Chen D; Yuan S; Wu X; Li H; Qiu Q; Zhan Z; Ye Y; Lian F; Liang L; Xu H; Yang X
    Clin Exp Rheumatol; 2014; 32(5):615-21. PubMed ID: 25068842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
    Chen YJ; Wu CY; Shen JL
    Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.
    Chang L; Zhang L; Jia H; Nie Z; Zhang L
    Medicine (Baltimore); 2020 Aug; 99(34):e21733. PubMed ID: 32846794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
    Fardet L; Dupuy A; Gain M; Kettaneh A; Chérin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Rybojad M
    Medicine (Baltimore); 2009 Mar; 88(2):91-97. PubMed ID: 19282699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis.
    Hoesly PM; Sluzevich JC; Jambusaria-Pahlajani A; Lesser ER; Heckman MG; Abril A
    J Am Acad Dermatol; 2019 May; 80(5):1364-1370. PubMed ID: 30458207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.
    Motomura K; Yamashita H; Yamada S; Takahashi Y; Kaneko H
    Rheumatol Int; 2019 Oct; 39(10):1733-1739. PubMed ID: 31444556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.
    Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S
    J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
    Front Immunol; 2022; 13():879266. PubMed ID: 35603153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
    So MW; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
    Springerplus; 2015; 4():240. PubMed ID: 26101728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
    Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
    J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
    Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Kono M; Akiyama M
    Clin Exp Rheumatol; 2018; 36(6):990-995. PubMed ID: 29745874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
    Bai Z; Shen G; Dong L
    Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
    Yu KH; Wu YJ; Kuo CF; See LC; Shen YM; Chang HC; Luo SF; Ho HH; Chen IJ
    Clin Rheumatol; 2011 Dec; 30(12):1595-601. PubMed ID: 21915609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.